Free shipping on all orders over $ 500

GSK 3787

Cat. No. M2033

All AbMole products are for research use only, cannot be used for human consumption.

GSK 3787 Structure
Synonym:

GSK3787

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 49 In stock
5mg USD 44 In stock
10mg USD 78 In stock
50mg USD 320 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK3787 is a potent and selective PPARbeta/delta antagonist. GSK3787 displays no measurable affinity for PPARα or PPARγ in vitro (pIC50< 5). GSK3787 has been shown to antagonize the induction of PPARδ-regulated target genes in skeletal muscle cells. In addition, GSK 3787 acts in a dual role as a weak agonist and antagonist towards PPARγ. In vivo and in vitro analysis indicates that the efficacy of GSK3787 to modulate PPARgamma activity is markedly lower than the efficacy of GSK3787 to act as a PPARbeta/delta antagonist. GSK3787 antagonized GW0742-induced expression of Angptl4 in mouse fibroblasts, mouse keratinocytes, and human cancer cell lines.

Customer Product Validations & Biological Datas
Source Toxicol Lett (2015). Figure 1. GSK 3787
Method Cell viability assay
Cell Lines H9c2 cells
Concentrations 1 μM
Incubation Time 24 h
Results Similarly, addition of GSK 3787 reduced the cytotoxic effect of DHA toward cellular metabolic activity in H9c2 cells.
Chemical Information
Molecular Weight 392.78
Formula C15H12ClF3N2O3S
CAS Number 188591-46-0
Solubility (25°C) DMSO 49 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] P Luz-Crawford, et al. Ann Rheum Dis . PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis

[2] Victor Samokhvalov, et al. Toxicol Lett . PPARδ signaling mediates the cytotoxicity of DHA in H9c2 cells

[3] Xiaodan Zhou, et al. Acta Vet Scand . Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ

[4] Palkar PS, et al. Mol Pharmacol. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.

[5] Shearer BG, et al. J Med Chem. Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist.

Related PPAR Products
SR1664

SR1664 is an antidiabetic compound that binds to PPARγ and can effectively inhibit CDK5-mediated phosphorylation of PPARγ with IC50 of 80 nM and Ki of 28.67 nM.

WY 14643 (Pirinixic Acid)

WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist.

Rosiglitazone

Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50=60 nM, Kd=40 nM). Rosiglitazone is an TRPC5 activator (EC50=30 μM) and TRPM3 inhibitor.

Rosiglitazone maleate

Rosiglitazone maleate (Avandia) is a potent and selective PPARγ ligand that binds to the PPARγ ligand-binding domain with a Kd value of 43 nM.

Ciprofibrate

Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK 3787, GSK3787 supplier, PPAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.